Skip to content
Search

Latest Stories

Vaping may damage your fertility, study warns women

Vaping may damage your fertility, study warns women

Concerningly, it also found that one in five British women vape while trying to get pregnant

Women who are trying to conceive should stop vaping as it may affect fertility, a study by the women’s health firm Hertility has suggested.


Analysis of blood samples from more than 8000 women revealed that vapers and smokers have lower levels of anti-mullerian hormone (AMH), which indicates how many eggs women have left in their ovaries.

Across all age groups, AMH levels were found to be lower in people who vaped than non-vapers, suggesting that vaping could accelerate age-related decline in egg reserve.

Concerningly, the report revealed that one in five British women vape while trying to get pregnant, with a significant portion also engaging in other lifestyle “vices” such as alcohol, drugs and smoking.

The study’s author, Dr Helen O’Neill, a lecturer in reproductive and molecular genetics at University College London and the chief executive of Hertility, recommended that women should quit vaping to avoid “thwarting” their chances of getting pregnant.

O’Neill said women planning to get pregnant should be given clear guidance of “no drinking, no vaping, no smoking, no drugs”, the Times reported.

According to her, this report is the first piece of evidence to show a link between fertility and vaping across a large population.

“It shows that AMH is suppressed in vapers compared to non-vapers, in a similar way to what has already been shown in smokers. AMH is a hormone used to assess ovarian [egg] reserve, and therefore fertility,” she said.

The report was based on data from 325,000 women in the UK, mostly in their 20s and 30s.

About 22 per cent of those actively trying to conceive said they vape regularly or occasionally, while 27 per cent of those aspiring to have children in the future reported engaging in vaping.

An equivalent number of women admitted to smoking tobacco cigarettes, which have already been proven to harm fertility.

The report also found that 7 per cent take recreational drugs, and 40 per cent drink alcohol weekly.

O’Neill said that women should be advised about the risks of drinking in the year before getting pregnant.

“Trying to drink in moderation can be a slippery slope when it comes to volumes and intake of wine or alcohol in a week. The best advice is to stop, as opposed to cutting down or trying in moderation,” she added.

Earlier studies have demonstrated that consuming alcohol, even in moderation, decreases the likelihood of conception compared to non-drinkers.

Last month the UK government passed a law prohibiting the sale of tobacco products to anyone born after 1 January 2009, aiming to create a smoke-free generation.

To address youth vaping, the government is also introducing new restrictions on vapes, including a complete ban on disposable vapes.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less